A top FDA official called for approving ‘puberty blockers’ for children despite admitting that they carrying an “increased risk of depression and suicide”.

Here’s the reporting from the Daily Signal (bold emphasis mine):

A team leader at the U.S. Food and Drug Administration recommended approving “puberty blockers” for teens who identify as transgender even while noting that a recent study showed these drugs are associated with an “increased risk in depression and suicidality.”

Many activists claim that children struggling with gender dysphoria (the persistent condition of identifying with the gender opposite their biological sex) must receive experimental drugs to make their bodies resemble bodies of the opposite sex to stop them from committing suicide, yet the FDA study suggested these drugs actually increase the risk of suicide.

In one email on Jan. 25, 2022, Shannon Sullivan, clinical team leader at the FDA’s Division of General Endocrinology, noted that the agency’s Division of Metabolism and Endocrinology Products performed a “safety review of the GnRH agonist class in pediatric patients in 2016/2017.” GnRH stands for “Gonadatropin-releasing hormone,” and GnRH agonists prevent the natural release of testosterone and estrogen that initiate puberty.

The conservative nonprofit America First Legal obtained the email in the discovery process of a lawsuit and made it available to The Daily Signal.

“Our review focused on suicidal ideation/depression, seizures, and bone health,” Sullivan wrote in the email. Although most of the minors in the study suffered from central precocious puberty (in which puberty starts too early), “a handful were transgender kids using the drugs off-label.”

“We found no effect on bone (after factoring in catch-up growth), including no increase in fracture risk,” she noted. “We did find increased risk of depression and suicidality, as well as increased seizure risk and we issued [safety-related labeling changes].”

Yet Sullivan went on to recommend approving GnRH agonists for minors.

The FDA’s Division of Urology, Obstetrics, and Gynecology, she wrote, “has done a patient listening session with trans kids and separately with trans adults, which I participated in, and there is definitely a need for these drugs to be approved for gender transition, as they are typically not covered by insurance and are expensive out of pocket.”

Sullivan also said that “no company has come in” to provide “GnRH agonists in the transgender population” yet, but “it was my understanding” that the FDA division “would take these applications if and when they do come in.”

These leftists don’t give a crap if children get depressed and kill themselves because of these brutal medicines. All they care about is pushing the trans-ideology instead of calling it what it is, mental illness. Instead of treating it and actually saving the lives of children, they would rather brainwash children into believing all of this is okay and destroy their lives.

I guess if they can’t abort as many kids as they want now that Roe is no longer the ‘law of the land’, they’ll trick them into killing themselves.